CSF p‐tau/ABeta ratio for Alzheimer's disease dementia. Five studies (140 cases and 293 non‐cases) evaluated the accuracy of the CSF p‐tau/ABeta ratio for conversion to Alzheimer's disease dementia (Figure 10). The sensitivities were between 80% and 96%, while the specificities were between 33% and 95%..